|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-7-9
|
|
pubmed:abstractText |
This study was designed to assess the anti-tumor activity of topotecan (TPT) in patients with advanced non-small-cell lung cancer (NSCLC) previously untreated with chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:FossellaF VFV,
pubmed-author:GlissonB SBS,
pubmed-author:HopeW GWG,
pubmed-author:HuberM HMH,
pubmed-author:KaneJJ,
pubmed-author:KempB LBL,
pubmed-author:KurieJ MJM,
pubmed-author:LeeJ JJJ,
pubmed-author:LeeJ SJS,
pubmed-author:LippmanS MSM,
pubmed-author:MurphyW KWK,
pubmed-author:Perez-SolerRR,
pubmed-author:RaberM NMN,
pubmed-author:RobinsonR ARA,
pubmed-author:ShinD MDM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
503-13
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8636764-Adenocarcinoma,
pubmed-meshheading:8636764-Adult,
pubmed-meshheading:8636764-Aged,
pubmed-meshheading:8636764-Antineoplastic Agents,
pubmed-meshheading:8636764-Camptothecin,
pubmed-meshheading:8636764-Carcinoma,
pubmed-meshheading:8636764-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8636764-Carcinoma, Squamous Cell,
pubmed-meshheading:8636764-Female,
pubmed-meshheading:8636764-Humans,
pubmed-meshheading:8636764-Leukopenia,
pubmed-meshheading:8636764-Lung Neoplasms,
pubmed-meshheading:8636764-Male,
pubmed-meshheading:8636764-Middle Aged,
pubmed-meshheading:8636764-Survival Rate,
pubmed-meshheading:8636764-Thrombocytopenia,
pubmed-meshheading:8636764-Topotecan,
pubmed-meshheading:8636764-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.
|
|
pubmed:affiliation |
Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
